董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Thomas T. Vo | 男 | Chief Executive Officer and Chairman of the Board | 53 | 219.74万美元 | 185.79 | 2026-04-23 |
| Warren Hosseinion | 男 | Director and President | 54 | 170.54万美元 | 3.03 | 2026-04-23 |
| Cheryl Grenas | 女 | Independent Director | 64 | 27.19万美元 | 0.07 | 2026-04-23 |
| Michael L. Reed | 男 | Independent Director | 67 | 27.76万美元 | 0.07 | 2026-04-23 |
| Kelvin Spears | -- | Director | 64 | 未披露 | 3.24 | 2026-04-23 |
| Scott J. Saunders | -- | Independent Director | 63 | 26.83万美元 | 0.06 | 2026-04-23 |
| Frank E. Jaumot | -- | Independent Director | 69 | 15.23万美元 | 0.06 | 2026-04-23 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Thomas T. Vo | 男 | Chief Executive Officer and Chairman of the Board | 53 | 219.74万美元 | 185.79 | 2026-04-23 |
| Warren Hosseinion | 男 | Director and President | 54 | 170.54万美元 | 3.03 | 2026-04-23 |
| Jon C. Bates | 男 | Chief Financial Officer | 56 | 92.42万美元 | 1.14 | 2026-04-23 |
| Elisa Luqman | 女 | Chief Legal Officer — SEC | 61 | 59.33万美元 | 1.05 | 2026-04-23 |
| Pamela Montgomery | 女 | Chief Legal Officer — Healthcare | 69 | 27.54万美元 | 0.64 | 2026-04-23 |
| Michael L. Chang | -- | Chief Medical Officer | 55 | 71.66万美元 | 8.60 | 2026-04-23 |
| Wesley Bamburg | 男 | Chief Operating Officer | 44 | 10.60万美元 | 未持股 | 2026-04-23 |
董事简历
中英对照 | 中文 | 英文- Thomas T. Vo
-
Thomas T. Vo于2022年4月1日被任命为公司首席执行官，并于2022年4月1日当选为董事会主席。自2010年以来，Vo博士一直担任公司附属公司的创始人和执行官。虽然不再执业，但沃医生在德克萨斯州休斯顿做了20多年的急诊内科医生。在2008年至2011年期间，Vo博士是独立的紧急医疗公司Neighbors Emergency Center的创始人和原始合伙人。从那时起，Vo医生参与了40多个独立的急诊和微型医院的开设。Vo博士拥有肯特州立大学生命科学理学学士学位，并在东北俄亥俄大学医学院获得医学博士学位。2004年，Vo博士还获得了莱斯大学的工商管理硕士学位。
Thomas T. Vo,was appointed as the Company's Chief Executive Officer on April 1, 2022 and elected, effective April 1, 2022, as the Chairman of the Board. Since 2010, Dr. Vo has served as the founder and executive officer of affiliates of the Company. Although no longer practicing, Dr. Vo worked as an emergency medicine physician in Houston, Texas, for over twenty years. Between 2008 and 2011, Dr. Vo served as a founder and original partner at the free-standing emergency health company, Neighbors Emergency Center. Since then, Dr. Vo has been involved with the opening of over 40 freestanding emergency departments and micro hospitals. Dr. Vo holds a Bachelor of Science in Life Sciences from Kent State University and received his Doctor of Medicine from North East Ohio Universities College of Medicine. In 2004, Dr. Vo also received his Master of Business Administration from Rice University. - Thomas T. Vo于2022年4月1日被任命为公司首席执行官，并于2022年4月1日当选为董事会主席。自2010年以来，Vo博士一直担任公司附属公司的创始人和执行官。虽然不再执业，但沃医生在德克萨斯州休斯顿做了20多年的急诊内科医生。在2008年至2011年期间，Vo博士是独立的紧急医疗公司Neighbors Emergency Center的创始人和原始合伙人。从那时起，Vo医生参与了40多个独立的急诊和微型医院的开设。Vo博士拥有肯特州立大学生命科学理学学士学位，并在东北俄亥俄大学医学院获得医学博士学位。2004年，Vo博士还获得了莱斯大学的工商管理硕士学位。
- Thomas T. Vo,was appointed as the Company's Chief Executive Officer on April 1, 2022 and elected, effective April 1, 2022, as the Chairman of the Board. Since 2010, Dr. Vo has served as the founder and executive officer of affiliates of the Company. Although no longer practicing, Dr. Vo worked as an emergency medicine physician in Houston, Texas, for over twenty years. Between 2008 and 2011, Dr. Vo served as a founder and original partner at the free-standing emergency health company, Neighbors Emergency Center. Since then, Dr. Vo has been involved with the opening of over 40 freestanding emergency departments and micro hospitals. Dr. Vo holds a Bachelor of Science in Life Sciences from Kent State University and received his Doctor of Medicine from North East Ohio Universities College of Medicine. In 2004, Dr. Vo also received his Master of Business Administration from Rice University.
- Warren Hosseinion
-
Warren Hosseinion目前担任Voyager Acquisition Corp.的董事会主席。他曾于2022年9月至2024年3月担任Altitude Acquisition Corporation（NASDAQ：ALTU）的董事长，并自2022年5月起担任Cardio Diagnostics，Inc.（NASDAQ：CDIO）的董事长。他还自2022年4月起担任Nutex Health，Inc.（NASDAQ：NUTX）的董事会董事兼总裁。Hosseinion博士是阿波罗医疗控股公司（NASDAQ：AMEH）的共同创始人，自2008年7月起担任其董事会成员，并于2008年7月至2017年12月担任其首席执行官，于2017年12月至2019年3月担任其共同首席执行官。Hosseinion博士于2019年4月至2022年3月担任Clinigence Holdings，Inc.董事会主席，并于2021年3月至2022年3月担任Clinigence Holdings，Inc.首席执行官。2001年，Hosseinion博士公司创立了ApolloMed。Hosseinion博士在旧金山大学获得生物学学士学位，在乔治城大学艺术与科学研究生院获得生理学和生物物理学硕士学位，在乔治城大学医学院获得医学学位。他在南加州大学医学中心完成了实习和内科住院医师实习。由于在医疗保健行业的经验，Hosseinion博士被选为PubCo的董事。
Warren Hosseinion has served as the Company's Non Executive Chairman of the Board since the consummation of the Business Combination in October 2022. He was Legacy Cardio's Non Executive Chairman of the Board from May 2022 and was on Legacy Cardio's Board of Directors beginning in November 2020. In March 2021, Legacy Cardio and Dr. Hosseinion entered into a consulting agreement under which he was retained to provide services in connection with a potential merger transaction. He continues to provide consulting services to the Company under that contract. He is also currently the President and a director of Nutex Health, Inc. (Nasdaq: NUTX), positions he has held since April 2022. He also serves as Chairman of the Board of Voyager Acquisition Corp. (Nasdaq: VACH), a position he has held since January 2024. In 2001, Dr. Hosseinion co founded Astrana Health, Inc. (Nasdaq: ASTH) (formerly, Apollo Medical Holdings, Inc. (Nasdaq: AMEH)) and served as a member of Astrana's Board of Directors from July 2008 to March 2019. He served as Astrana's Chief Executive Officer from July 2008 to December 2017 and its Co Chief Executive Officer from December 2017 to March 2019. Dr. Hosseinion received his B.S. in Biology from the University of San Francisco, his M.S. in Physiology and Biophysics from the Georgetown University Graduate School of Arts and Sciences, his Medical Degree from the Georgetown University School of Medicine and completed his residency in internal medicine from the Los Angeles County University of Southern California Medical Center. - Warren Hosseinion目前担任Voyager Acquisition Corp.的董事会主席。他曾于2022年9月至2024年3月担任Altitude Acquisition Corporation（NASDAQ：ALTU）的董事长，并自2022年5月起担任Cardio Diagnostics，Inc.（NASDAQ：CDIO）的董事长。他还自2022年4月起担任Nutex Health，Inc.（NASDAQ：NUTX）的董事会董事兼总裁。Hosseinion博士是阿波罗医疗控股公司（NASDAQ：AMEH）的共同创始人，自2008年7月起担任其董事会成员，并于2008年7月至2017年12月担任其首席执行官，于2017年12月至2019年3月担任其共同首席执行官。Hosseinion博士于2019年4月至2022年3月担任Clinigence Holdings，Inc.董事会主席，并于2021年3月至2022年3月担任Clinigence Holdings，Inc.首席执行官。2001年，Hosseinion博士公司创立了ApolloMed。Hosseinion博士在旧金山大学获得生物学学士学位，在乔治城大学艺术与科学研究生院获得生理学和生物物理学硕士学位，在乔治城大学医学院获得医学学位。他在南加州大学医学中心完成了实习和内科住院医师实习。由于在医疗保健行业的经验，Hosseinion博士被选为PubCo的董事。
- Warren Hosseinion has served as the Company's Non Executive Chairman of the Board since the consummation of the Business Combination in October 2022. He was Legacy Cardio's Non Executive Chairman of the Board from May 2022 and was on Legacy Cardio's Board of Directors beginning in November 2020. In March 2021, Legacy Cardio and Dr. Hosseinion entered into a consulting agreement under which he was retained to provide services in connection with a potential merger transaction. He continues to provide consulting services to the Company under that contract. He is also currently the President and a director of Nutex Health, Inc. (Nasdaq: NUTX), positions he has held since April 2022. He also serves as Chairman of the Board of Voyager Acquisition Corp. (Nasdaq: VACH), a position he has held since January 2024. In 2001, Dr. Hosseinion co founded Astrana Health, Inc. (Nasdaq: ASTH) (formerly, Apollo Medical Holdings, Inc. (Nasdaq: AMEH)) and served as a member of Astrana's Board of Directors from July 2008 to March 2019. He served as Astrana's Chief Executive Officer from July 2008 to December 2017 and its Co Chief Executive Officer from December 2017 to March 2019. Dr. Hosseinion received his B.S. in Biology from the University of San Francisco, his M.S. in Physiology and Biophysics from the Georgetown University Graduate School of Arts and Sciences, his Medical Degree from the Georgetown University School of Medicine and completed his residency in internal medicine from the Los Angeles County University of Southern California Medical Center.
- Cheryl Grenas
-
Cheryl Grenas，自2022年4月1日起担任本公司董事。自2018年3月起，Grenas女士担任贝莱尔行为医院的首席护理官。从2017年7月到2018年3月，她是休斯顿大都市区初创企业和现有独立急诊部门的顾问。2015年8月至2017年7月，她担任邻居应急中心（独立应急部门）区域设施主任。格雷纳斯女士曾在美国海军服役20年，获得中尉指挥官军衔，曾两次部署支持伊拉克自由行动（2005年）和持久自由行动（2011年）。在服役期间，她获得了两枚海军表彰奖章和四枚海军成就奖章。Grenas女士拥有Prairie View农工大学护理学学士学位和护理学硕士学位。
Cheryl Grenas,has been a director of the Company since April 1, 2022. Since March 2018, Ms. Grenas has served as the Chief Nursing Officer at Behavioral Hospital of Bellaire. From July 2017 to March 2018, she was a consultant to start-up and existing freestanding emergency departments in the Houston metropolitan area. From August 2015 to July 2017, she was the Regional Facility Director at Neighbors Emergency Center (Free Standing Emergency Departments). Ms. Grenas served in the United States Navy for 20 years, achieved the rank of Lieutenant Commander, and is a veteran of two deployments in support of Operation Iraqi Freedom (2005) and Operation Enduring Freedom (2011). She was awarded two Navy Commendation Medals and four Navy Achievement Medals during her service. Ms. Grenas, holds a Bachelor of Science in Nursing and a Master of Science in nursing from Prairie View A&M University. - Cheryl Grenas，自2022年4月1日起担任本公司董事。自2018年3月起，Grenas女士担任贝莱尔行为医院的首席护理官。从2017年7月到2018年3月，她是休斯顿大都市区初创企业和现有独立急诊部门的顾问。2015年8月至2017年7月，她担任邻居应急中心（独立应急部门）区域设施主任。格雷纳斯女士曾在美国海军服役20年，获得中尉指挥官军衔，曾两次部署支持伊拉克自由行动（2005年）和持久自由行动（2011年）。在服役期间，她获得了两枚海军表彰奖章和四枚海军成就奖章。Grenas女士拥有Prairie View农工大学护理学学士学位和护理学硕士学位。
- Cheryl Grenas,has been a director of the Company since April 1, 2022. Since March 2018, Ms. Grenas has served as the Chief Nursing Officer at Behavioral Hospital of Bellaire. From July 2017 to March 2018, she was a consultant to start-up and existing freestanding emergency departments in the Houston metropolitan area. From August 2015 to July 2017, she was the Regional Facility Director at Neighbors Emergency Center (Free Standing Emergency Departments). Ms. Grenas served in the United States Navy for 20 years, achieved the rank of Lieutenant Commander, and is a veteran of two deployments in support of Operation Iraqi Freedom (2005) and Operation Enduring Freedom (2011). She was awarded two Navy Commendation Medals and four Navy Achievement Medals during her service. Ms. Grenas, holds a Bachelor of Science in Nursing and a Master of Science in nursing from Prairie View A&M University.
- Michael L. Reed
-
Michael L. Reed，自2022年4月1日起担任本公司董事。自2018年1月以来，Reed先生一直是一名独立顾问，在急诊医学、住院医疗、医院运营、基于风险的付款人合同、基于价值的护理以及医师执业运营和发展等领域提供咨询服务。从2019年1月至2020年1月，里德先生担任基于价值的肿瘤护理公司肿瘤研究所的业务发展和战略合作伙伴关系高级副总裁。2018年4月至2018年12月，里德先生担任Turtle Peak Customer Service，LLC的首席执行官，该公司是一家总部位于内华达州拉斯维加斯的私人客户服务公司。自2017年8月以来，里德先生一直担任NueHealth，LLC的高级顾问，该公司位于堪萨斯州利伍德，是一家私营开发商，也是低成本医疗保健中心的投资者。从2009年7月到2013年10月，里德先生担任Team Health Hospital Medicine的总裁兼首席执行官，该公司是TeamHealth旗下的一个部门，TeamHealth曾是一家上市公司，于2017年被黑石收购。此外，从2001年12月至2004年11月，他还担任Pinnacle Health System的首席运营官，这是一家提供门诊、住院、报销、计费和医疗管理的医疗保健解决方案公司。里德先生拥有加州州立大学卫生服务管理理学学士学位，并在加州大学洛杉矶分校获得公共卫生硕士学位。
Michael L. Reed,has been a director of the Company since April 1, 2022. Mr. Reed has been an independent consultant providing advisory services in the areas of emergency medicine, hospitalist medicine, hospital operations, risk-based payor contracts, value-based care, and physician practice operations and development since January of 2018. From January 2019 to January 2020, Mr. Reed was Senior Vice President of Business Development and Strategic Partnerships of the Oncology Institute, a value-based oncology care company. From April 2018 to December 2018, Mr. Reed served as the Chief Executive Officer of Turtle Peak Customer Service, LLC, a Las Vegas, Nevada-based privately-held customer service company. Since August 2017, Mr. Reed has served as Senior Advisor to NueHealth, LLC, based in Leawood, Kansas, a privately-held developer and investor in lower-cost healthcare centers. From July 2009 to October 2013, Mr. Reed was President and Chief Executive Officer of Team Health Hospital Medicine, a division of TeamHealth, a once publicly-traded company that was acquired by Blackstone in 2017. In addition, from December 2001 to November 2004, he served as the Chief Operating Officer of Pinnacle Health System, a health care solutions company providing outpatient, inpatient, claims, billing, and medical management. Mr. Reed holds a Bachelor of Science in Health Services Management from California State University and received his Master of Public Health from UCLA. - Michael L. Reed，自2022年4月1日起担任本公司董事。自2018年1月以来，Reed先生一直是一名独立顾问，在急诊医学、住院医疗、医院运营、基于风险的付款人合同、基于价值的护理以及医师执业运营和发展等领域提供咨询服务。从2019年1月至2020年1月，里德先生担任基于价值的肿瘤护理公司肿瘤研究所的业务发展和战略合作伙伴关系高级副总裁。2018年4月至2018年12月，里德先生担任Turtle Peak Customer Service，LLC的首席执行官，该公司是一家总部位于内华达州拉斯维加斯的私人客户服务公司。自2017年8月以来，里德先生一直担任NueHealth，LLC的高级顾问，该公司位于堪萨斯州利伍德，是一家私营开发商，也是低成本医疗保健中心的投资者。从2009年7月到2013年10月，里德先生担任Team Health Hospital Medicine的总裁兼首席执行官，该公司是TeamHealth旗下的一个部门，TeamHealth曾是一家上市公司，于2017年被黑石收购。此外，从2001年12月至2004年11月，他还担任Pinnacle Health System的首席运营官，这是一家提供门诊、住院、报销、计费和医疗管理的医疗保健解决方案公司。里德先生拥有加州州立大学卫生服务管理理学学士学位，并在加州大学洛杉矶分校获得公共卫生硕士学位。
- Michael L. Reed,has been a director of the Company since April 1, 2022. Mr. Reed has been an independent consultant providing advisory services in the areas of emergency medicine, hospitalist medicine, hospital operations, risk-based payor contracts, value-based care, and physician practice operations and development since January of 2018. From January 2019 to January 2020, Mr. Reed was Senior Vice President of Business Development and Strategic Partnerships of the Oncology Institute, a value-based oncology care company. From April 2018 to December 2018, Mr. Reed served as the Chief Executive Officer of Turtle Peak Customer Service, LLC, a Las Vegas, Nevada-based privately-held customer service company. Since August 2017, Mr. Reed has served as Senior Advisor to NueHealth, LLC, based in Leawood, Kansas, a privately-held developer and investor in lower-cost healthcare centers. From July 2009 to October 2013, Mr. Reed was President and Chief Executive Officer of Team Health Hospital Medicine, a division of TeamHealth, a once publicly-traded company that was acquired by Blackstone in 2017. In addition, from December 2001 to November 2004, he served as the Chief Operating Officer of Pinnacle Health System, a health care solutions company providing outpatient, inpatient, claims, billing, and medical management. Mr. Reed holds a Bachelor of Science in Health Services Management from California State University and received his Master of Public Health from UCLA.
- Kelvin Spears
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Scott J. Saunders
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Frank E. Jaumot
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
高管简历
中英对照 | 中文 | 英文- Thomas T. Vo
Thomas T. Vo于2022年4月1日被任命为公司首席执行官，并于2022年4月1日当选为董事会主席。自2010年以来，Vo博士一直担任公司附属公司的创始人和执行官。虽然不再执业，但沃医生在德克萨斯州休斯顿做了20多年的急诊内科医生。在2008年至2011年期间，Vo博士是独立的紧急医疗公司Neighbors Emergency Center的创始人和原始合伙人。从那时起，Vo医生参与了40多个独立的急诊和微型医院的开设。Vo博士拥有肯特州立大学生命科学理学学士学位，并在东北俄亥俄大学医学院获得医学博士学位。2004年，Vo博士还获得了莱斯大学的工商管理硕士学位。
Thomas T. Vo,was appointed as the Company's Chief Executive Officer on April 1, 2022 and elected, effective April 1, 2022, as the Chairman of the Board. Since 2010, Dr. Vo has served as the founder and executive officer of affiliates of the Company. Although no longer practicing, Dr. Vo worked as an emergency medicine physician in Houston, Texas, for over twenty years. Between 2008 and 2011, Dr. Vo served as a founder and original partner at the free-standing emergency health company, Neighbors Emergency Center. Since then, Dr. Vo has been involved with the opening of over 40 freestanding emergency departments and micro hospitals. Dr. Vo holds a Bachelor of Science in Life Sciences from Kent State University and received his Doctor of Medicine from North East Ohio Universities College of Medicine. In 2004, Dr. Vo also received his Master of Business Administration from Rice University.- Thomas T. Vo于2022年4月1日被任命为公司首席执行官，并于2022年4月1日当选为董事会主席。自2010年以来，Vo博士一直担任公司附属公司的创始人和执行官。虽然不再执业，但沃医生在德克萨斯州休斯顿做了20多年的急诊内科医生。在2008年至2011年期间，Vo博士是独立的紧急医疗公司Neighbors Emergency Center的创始人和原始合伙人。从那时起，Vo医生参与了40多个独立的急诊和微型医院的开设。Vo博士拥有肯特州立大学生命科学理学学士学位，并在东北俄亥俄大学医学院获得医学博士学位。2004年，Vo博士还获得了莱斯大学的工商管理硕士学位。
- Thomas T. Vo,was appointed as the Company's Chief Executive Officer on April 1, 2022 and elected, effective April 1, 2022, as the Chairman of the Board. Since 2010, Dr. Vo has served as the founder and executive officer of affiliates of the Company. Although no longer practicing, Dr. Vo worked as an emergency medicine physician in Houston, Texas, for over twenty years. Between 2008 and 2011, Dr. Vo served as a founder and original partner at the free-standing emergency health company, Neighbors Emergency Center. Since then, Dr. Vo has been involved with the opening of over 40 freestanding emergency departments and micro hospitals. Dr. Vo holds a Bachelor of Science in Life Sciences from Kent State University and received his Doctor of Medicine from North East Ohio Universities College of Medicine. In 2004, Dr. Vo also received his Master of Business Administration from Rice University.
- Warren Hosseinion
Warren Hosseinion目前担任Voyager Acquisition Corp.的董事会主席。他曾于2022年9月至2024年3月担任Altitude Acquisition Corporation（NASDAQ：ALTU）的董事长，并自2022年5月起担任Cardio Diagnstics，Inc.（NASDAQ：CDIO）的董事长。他还自2022年4月起担任Nutex Health，Inc.（NASDAQ：NUTX）的董事会董事兼总裁。Hosseinion博士是阿波罗医疗控股公司（NASDAQ：AMEH）的共同创始人，自2008年7月起担任其董事会成员，并于2008年7月至2017年12月担任其首席执行官，于2017年12月至2019年3月担任其共同首席执行官。Hosseinion博士于2019年4月至2022年3月担任Clinigence Holdings，Inc.董事会主席，并于2021年3月至2022年3月担任Clinigence Holdings，Inc.首席执行官。2001年，Hosseinion博士公司创立了ApolloMed。Hosseinion博士在旧金山大学获得生物学学士学位，在乔治城大学艺术与科学研究生院获得生理学和生物物理学硕士学位，在乔治城大学医学院获得医学学位。他在南加州大学医学中心完成了实习和内科住院医师实习。由于在医疗保健行业的经验，Hosseinion博士被选为PubCo的董事。
Warren Hosseinion has served as the Company's Non Executive Chairman of the Board since the consummation of the Business Combination in October 2022. He was Legacy Cardio's Non Executive Chairman of the Board from May 2022 and was on Legacy Cardio's Board of Directors beginning in November 2020. In March 2021, Legacy Cardio and Dr. Hosseinion entered into a consulting agreement under which he was retained to provide services in connection with a potential merger transaction. He continues to provide consulting services to the Company under that contract. He is also currently the President and a director of Nutex Health, Inc. (Nasdaq: NUTX), positions he has held since April 2022. He also serves as Chairman of the Board of Voyager Acquisition Corp. (Nasdaq: VACH), a position he has held since January 2024. In 2001, Dr. Hosseinion co founded Astrana Health, Inc. (Nasdaq: ASTH) (formerly, Apollo Medical Holdings, Inc. (Nasdaq: AMEH)) and served as a member of Astrana's Board of Directors from July 2008 to March 2019. He served as Astrana's Chief Executive Officer from July 2008 to December 2017 and its Co Chief Executive Officer from December 2017 to March 2019. Dr. Hosseinion received his B.S. in Biology from the University of San Francisco, his M.S. in Physiology and Biophysics from the Georgetown University Graduate School of Arts and Sciences, his Medical Degree from the Georgetown University School of Medicine and completed his residency in internal medicine from the Los Angeles County University of Southern California Medical Center.- Warren Hosseinion目前担任Voyager Acquisition Corp.的董事会主席。他曾于2022年9月至2024年3月担任Altitude Acquisition Corporation（NASDAQ：ALTU）的董事长，并自2022年5月起担任Cardio Diagnstics，Inc.（NASDAQ：CDIO）的董事长。他还自2022年4月起担任Nutex Health，Inc.（NASDAQ：NUTX）的董事会董事兼总裁。Hosseinion博士是阿波罗医疗控股公司（NASDAQ：AMEH）的共同创始人，自2008年7月起担任其董事会成员，并于2008年7月至2017年12月担任其首席执行官，于2017年12月至2019年3月担任其共同首席执行官。Hosseinion博士于2019年4月至2022年3月担任Clinigence Holdings，Inc.董事会主席，并于2021年3月至2022年3月担任Clinigence Holdings，Inc.首席执行官。2001年，Hosseinion博士公司创立了ApolloMed。Hosseinion博士在旧金山大学获得生物学学士学位，在乔治城大学艺术与科学研究生院获得生理学和生物物理学硕士学位，在乔治城大学医学院获得医学学位。他在南加州大学医学中心完成了实习和内科住院医师实习。由于在医疗保健行业的经验，Hosseinion博士被选为PubCo的董事。
- Warren Hosseinion has served as the Company's Non Executive Chairman of the Board since the consummation of the Business Combination in October 2022. He was Legacy Cardio's Non Executive Chairman of the Board from May 2022 and was on Legacy Cardio's Board of Directors beginning in November 2020. In March 2021, Legacy Cardio and Dr. Hosseinion entered into a consulting agreement under which he was retained to provide services in connection with a potential merger transaction. He continues to provide consulting services to the Company under that contract. He is also currently the President and a director of Nutex Health, Inc. (Nasdaq: NUTX), positions he has held since April 2022. He also serves as Chairman of the Board of Voyager Acquisition Corp. (Nasdaq: VACH), a position he has held since January 2024. In 2001, Dr. Hosseinion co founded Astrana Health, Inc. (Nasdaq: ASTH) (formerly, Apollo Medical Holdings, Inc. (Nasdaq: AMEH)) and served as a member of Astrana's Board of Directors from July 2008 to March 2019. He served as Astrana's Chief Executive Officer from July 2008 to December 2017 and its Co Chief Executive Officer from December 2017 to March 2019. Dr. Hosseinion received his B.S. in Biology from the University of San Francisco, his M.S. in Physiology and Biophysics from the Georgetown University Graduate School of Arts and Sciences, his Medical Degree from the Georgetown University School of Medicine and completed his residency in internal medicine from the Los Angeles County University of Southern California Medical Center.
- Jon C. Bates
乔恩·C·贝茨被任命为公司首席财务官，自2022年6月30日起生效。从2006年到2022年6月，贝茨先生在U.S. Physical Therapy, Inc.（纽约证券交易所代码：USPH）担任会计/公司财务副总裁，该公司是最大的上市、纯全国性门诊物理治疗诊所运营商和工伤预防服务提供商之一。在加入USPH之前，Bates先生曾在Commerciant，L.P.担任首席财务官和首席会计官，在National Alarm Technologies LLC担任首席会计官/公司财务总监，在American Residential Services，Inc.担任助理公司财务总监，在Arthur Andersen LLP担任高级审计师。他的专长领域包括战略财务规划、风险评估和评估、内部审计/SOX报告、估值和交易收购等等。Bates先生是一名注册会计师，拥有德克萨斯大学奥斯汀分校的工商管理学士学位，还获得了休斯顿大学的工商管理硕士学位。
Jon C. Bates,was appointed as the Company's Chief Financial Officer effective June 30, 2022. From 2006 until June 2022, Mr. Bates served as Vice President of Accounting/Corporate Controller at U.S. Physical Therapy, Inc., (NYSE: USPH), one of the largest publicly traded, pure-play national operators of outpatient physical therapy clinics and provider of industrial injury prevention services. Before joining USPH, Mr. Bates served as Chief Financial Officer and Chief Accounting Officer at Commerciant, L.P., Chief Accounting Officer/Corporate Controller at National Alarm Technologies LLC, Assistant Corporate Controller at American Residential Services, Inc., and a Senior Auditor at Arthur Andersen LLP. His areas of expertise include strategic financial planning, risk assessment & evaluation, Internal Audit/SOX reporting, valuation and deal acquisition, and many more. Mr. Bates is a Certified Public Accountant, holds a Bachelor of Business Administration from University of Texas at Austin and also received his Master of Business Administration from University of Houston.- 乔恩·C·贝茨被任命为公司首席财务官，自2022年6月30日起生效。从2006年到2022年6月，贝茨先生在U.S. Physical Therapy, Inc.（纽约证券交易所代码：USPH）担任会计/公司财务副总裁，该公司是最大的上市、纯全国性门诊物理治疗诊所运营商和工伤预防服务提供商之一。在加入USPH之前，Bates先生曾在Commerciant，L.P.担任首席财务官和首席会计官，在National Alarm Technologies LLC担任首席会计官/公司财务总监，在American Residential Services，Inc.担任助理公司财务总监，在Arthur Andersen LLP担任高级审计师。他的专长领域包括战略财务规划、风险评估和评估、内部审计/SOX报告、估值和交易收购等等。Bates先生是一名注册会计师，拥有德克萨斯大学奥斯汀分校的工商管理学士学位，还获得了休斯顿大学的工商管理硕士学位。
- Jon C. Bates,was appointed as the Company's Chief Financial Officer effective June 30, 2022. From 2006 until June 2022, Mr. Bates served as Vice President of Accounting/Corporate Controller at U.S. Physical Therapy, Inc., (NYSE: USPH), one of the largest publicly traded, pure-play national operators of outpatient physical therapy clinics and provider of industrial injury prevention services. Before joining USPH, Mr. Bates served as Chief Financial Officer and Chief Accounting Officer at Commerciant, L.P., Chief Accounting Officer/Corporate Controller at National Alarm Technologies LLC, Assistant Corporate Controller at American Residential Services, Inc., and a Senior Auditor at Arthur Andersen LLP. His areas of expertise include strategic financial planning, risk assessment & evaluation, Internal Audit/SOX reporting, valuation and deal acquisition, and many more. Mr. Bates is a Certified Public Accountant, holds a Bachelor of Business Administration from University of Texas at Austin and also received his Master of Business Administration from University of Houston.
- Elisa Luqman
Elisa Luqman，曾担任Cardio Diagnostics Holdings，Inc.自2021年3月起担任首席财务官。2021年3月，Legacy Cardio和Luqman女士签订了一项咨询协议，根据该协议，她被保留提供与潜在合并交易相关的服务。自2022年4月以来，Luqman女士还担任Nutex Health， Inc.（“Nutex”）的首席法律官（SEC），这是一家由医生领导的技术支持的医疗保健服务公司。她在合并交结束时获得该职位，其中她的雇主Clinigence Holdings， Inc.（“Clinigence”）是幸存的实体。从2019年10月到合并，她担任Clinigence的首席财务官、执行财务副总裁和总法律顾问。从2019年10月到2021年2月，她还担任Clinigence的董事。在Clinigence任职期间，Luqman女士负责维护公司的会计记录和报表，准备其美国证券交易委员会（SEC）文件，并监督合规要求。她是Clinigence团队的重要成员，负责获得公司的纳斯达克上市并完成与Nutex的反向合并。在Nutex， Luqman女士继续负责准备其SEC文件和监督合规要求。Luqman女士是bigVault Storage Technologies（一家基于云的文件托管公司，于2006年2月被Digi-Data Corporation收购）的联合创始人。从2006年3月到2009年2月，Luqman女士被聘为Digi-Data Corporation保险库服务部门的首席运营官，随后在她任职Digi-Data Corporation期间，她成为整个公司的总法律顾问。在此期间，她负责收购、合并、专利、客户、供应商和员工合同，并与Digi-Data的外部法律顾问公司密切合作。2009年3月，她重新加入iGambit Inc.（“IGMB”），担任首席财务官和总法律顾问。Luqman女士一直监督并负责IGMB的SEC备案、FINRA备案和上市公司合规要求，从2010年向SEC提交的最初Form 10备案到2019年10月与Clinigence Holdings， Inc.的反向合并。Luqman女士获得Hofstra大学的学士学位、法学博士学位和金融MBA学位。Luqman女士是纽约和新泽西律师协会的会员。
Elisa Luqman has served as Cardio Diagnostics Holdings,Inc.'s Chief Financial Officer on a part time basis since March 2021. In March 2021, Legacy Cardio and Ms. Luqman entered into a consulting agreement under which she was retained to provide services in connection with a potential merger transaction. Since April 2022, Ms. Luqman has also been serving as Chief Legal Officer (SEC) for Nutex Health, Inc. ("Nutex"), a physician led, technology enabled healthcare services company. She attained that position upon the closing of a merger transaction in which her employer, Clinigence Holdings, Inc. ("Clinigence"), was the surviving entity. She served as the Chief Financial Officer, Executive Vice President Finance and General Counsel of Clinigence from October 2019 until the merger. She also served as a director of Clinigence from October 2019 to February 2021. At Clinigence, Ms. Luqman was responsible for maintaining the corporation's accounting records and statements, preparing its SEC filings and overseeing compliance requirements. She was an integral member of the Clinigence team responsible for obtaining the company's NASDAQ listing and completing the reverse merger with Nutex. At Nutex Ms. Luqman continues to be responsible for preparing its SEC filings and overseeing compliance requirements. Ms. Luqman co founded bigVault Storage Technologies, a cloud based file hosting company acquired by Digi Data Corporation in February 2006. From March 2006 through February 2009, Ms. Luqman was employed as Chief Operating Officer of the Vault Services Division of Digi Data Corporation, and subsequently during her tenure with Digi Data Corporation she became General Counsel for the entire corporation. In that capacity she was responsible for acquisitions, mergers, patents, customer, supplier, and employee contracts, and worked very closely with Digi Data's outside counsel firms. In March 2009, Ms. Luqman rejoined iGambit Inc. ("IGMB") as Chief Financial Officer and General Counsel. Ms. Luqman has overseen and been responsible for IGMB's SEC filings, FINRA filings and public company compliance requirements from its initial Form 10 filing with the SEC in 2010 through its reverse merger with Clinigence Holdings, Inc. in October 2019. Ms. Luqman received a BA degree, a JD in Law, and an MBA Degree in Finance from Hofstra University. Ms. Luqman is a member of the bar in New York and New Jersey and Florida in house counsel Bar.- Elisa Luqman，曾担任Cardio Diagnostics Holdings，Inc.自2021年3月起担任首席财务官。2021年3月，Legacy Cardio和Luqman女士签订了一项咨询协议，根据该协议，她被保留提供与潜在合并交易相关的服务。自2022年4月以来，Luqman女士还担任Nutex Health， Inc.（“Nutex”）的首席法律官（SEC），这是一家由医生领导的技术支持的医疗保健服务公司。她在合并交结束时获得该职位，其中她的雇主Clinigence Holdings， Inc.（“Clinigence”）是幸存的实体。从2019年10月到合并，她担任Clinigence的首席财务官、执行财务副总裁和总法律顾问。从2019年10月到2021年2月，她还担任Clinigence的董事。在Clinigence任职期间，Luqman女士负责维护公司的会计记录和报表，准备其美国证券交易委员会（SEC）文件，并监督合规要求。她是Clinigence团队的重要成员，负责获得公司的纳斯达克上市并完成与Nutex的反向合并。在Nutex， Luqman女士继续负责准备其SEC文件和监督合规要求。Luqman女士是bigVault Storage Technologies（一家基于云的文件托管公司，于2006年2月被Digi-Data Corporation收购）的联合创始人。从2006年3月到2009年2月，Luqman女士被聘为Digi-Data Corporation保险库服务部门的首席运营官，随后在她任职Digi-Data Corporation期间，她成为整个公司的总法律顾问。在此期间，她负责收购、合并、专利、客户、供应商和员工合同，并与Digi-Data的外部法律顾问公司密切合作。2009年3月，她重新加入iGambit Inc.（“IGMB”），担任首席财务官和总法律顾问。Luqman女士一直监督并负责IGMB的SEC备案、FINRA备案和上市公司合规要求，从2010年向SEC提交的最初Form 10备案到2019年10月与Clinigence Holdings， Inc.的反向合并。Luqman女士获得Hofstra大学的学士学位、法学博士学位和金融MBA学位。Luqman女士是纽约和新泽西律师协会的会员。
- Elisa Luqman has served as Cardio Diagnostics Holdings,Inc.'s Chief Financial Officer on a part time basis since March 2021. In March 2021, Legacy Cardio and Ms. Luqman entered into a consulting agreement under which she was retained to provide services in connection with a potential merger transaction. Since April 2022, Ms. Luqman has also been serving as Chief Legal Officer (SEC) for Nutex Health, Inc. ("Nutex"), a physician led, technology enabled healthcare services company. She attained that position upon the closing of a merger transaction in which her employer, Clinigence Holdings, Inc. ("Clinigence"), was the surviving entity. She served as the Chief Financial Officer, Executive Vice President Finance and General Counsel of Clinigence from October 2019 until the merger. She also served as a director of Clinigence from October 2019 to February 2021. At Clinigence, Ms. Luqman was responsible for maintaining the corporation's accounting records and statements, preparing its SEC filings and overseeing compliance requirements. She was an integral member of the Clinigence team responsible for obtaining the company's NASDAQ listing and completing the reverse merger with Nutex. At Nutex Ms. Luqman continues to be responsible for preparing its SEC filings and overseeing compliance requirements. Ms. Luqman co founded bigVault Storage Technologies, a cloud based file hosting company acquired by Digi Data Corporation in February 2006. From March 2006 through February 2009, Ms. Luqman was employed as Chief Operating Officer of the Vault Services Division of Digi Data Corporation, and subsequently during her tenure with Digi Data Corporation she became General Counsel for the entire corporation. In that capacity she was responsible for acquisitions, mergers, patents, customer, supplier, and employee contracts, and worked very closely with Digi Data's outside counsel firms. In March 2009, Ms. Luqman rejoined iGambit Inc. ("IGMB") as Chief Financial Officer and General Counsel. Ms. Luqman has overseen and been responsible for IGMB's SEC filings, FINRA filings and public company compliance requirements from its initial Form 10 filing with the SEC in 2010 through its reverse merger with Clinigence Holdings, Inc. in October 2019. Ms. Luqman received a BA degree, a JD in Law, and an MBA Degree in Finance from Hofstra University. Ms. Luqman is a member of the bar in New York and New Jersey and Florida in house counsel Bar.
- Pamela Montgomery
Pamela Montgomery，自2022年4月1日起担任Nutex Health Inc.首席法务官（SEC）。自2019年10月至合并前，她曾担任Clinigence Holdings，Inc.的首席财务官、财务执行副总裁和总法律顾问。她还在2019年10月至2021年2月期间担任Clinigence Holdings，Inc.的董事。在Clinigence Holdings，Inc.，卢克曼负责维护公司的会计记录和报表，准备提交给SEC的文件，并监督合规要求。她是Clinigence Holdings，Inc.团队的重要成员，负责获得其在纳斯达克股票市场有限责任公司（“纳斯达克”）的上市，并完成与该公司的反向合并。在该公司，Luqman女士继续负责准备提交给SEC的文件，并监督合规要求。Luqman女士自2021年3月起担任Cardio的首席财务官。此外，卢克曼还与人共同创立了bigVault Storage Technologies，这是一家基于云的文件托管公司，于2006年2月被Digi-Data Corporation收购。从2006年3月至2009年2月，Luqman女士受聘担任Digi-Data公司保险库服务部首席运营官，随后在Digi-Data公司任职期间，她成为整个公司的总法律顾问。在这个职位上，她负责收购、合并、专利、客户、供应商和员工合同，并与Digi-Data的外部咨询公司密切合作。2009年3月，Luqman女士重新加入iGambit公司（“IGMB”），担任首席财务官和总法律顾问。从2010年IGMB首次向SEC提交表格10，到2019年10月IGMB与Clinigence Holdings，Inc.进行反向并购，卢克曼一直监督并负责IGMB向SEC提交的文件、FINRA文件和上市公司合规要求。Luqman女士在霍夫斯特拉大学获得文学学士、法学博士和金融专业工商管理硕士学位。卢克曼女士是纽约和新泽西律师协会的会员。
Pamela Montgomery,has served as the Chief Legal Officer (SEC) of Nutex Health Inc. Company since April 1, 2022. She served as the Chief Financial Officer, Executive Vice President Finance and General Counsel of Clinigence Holdings, Inc. from October 2019 until the Merger. She also served as a director of Clinigence Holdings, Inc. from October 2019 to February 2021. At Clinigence Holdings, Inc., Ms. Luqman was responsible for maintaining the corporation's accounting records and statements, preparing its SEC filings and overseeing compliance requirements. She was an integral member of the Clinigence Holdings, Inc. team responsible for obtaining its NASDAQ Stock Market LLC ("NASDAQ") listing and completing the reverse merger with the Company. At the Company, Ms. Luqman continues to be responsible for preparing its SEC filings and overseeing compliance requirements. Ms. Luqman has served as Chief Financial Officer of Cardio since March 2021. In addition, Ms. Luqman co-founded bigVault Storage Technologies, a cloud- based file hosting company acquired by Digi-Data Corporation in February 2006. From March 2006 through February 2009, Ms. Luqman was employed as Chief Operating Officer of the Vault Services Division of Digi-Data Corporation, and subsequently during her tenure with Digi-Data Corporation she became General Counsel for the entire corporation. In that capacity she was responsible for acquisitions, mergers, patents, customer, supplier, and employee contracts, and worked very closely with Digi- Data's outside counsel firms. In March 2009, Ms. Luqman rejoined iGambit Inc. ("IGMB") as Chief Financial Officer and General Counsel. Ms. Luqman has overseen and been responsible for IGMB's SEC filings, FINRA filings and public company compliance requirements from its initial Form 10 filing with the SEC in 2010 through its reverse merger with Clinigence Holdings, Inc. in October 2019. Ms. Luqman received a Bachelor of Arts, a Juris Doctor, and a Master of Business Administration with a specialization in Finance from Hofstra University. Ms. Luqman is a member of the bar in New York and New Jersey.- Pamela Montgomery，自2022年4月1日起担任Nutex Health Inc.首席法务官（SEC）。自2019年10月至合并前，她曾担任Clinigence Holdings，Inc.的首席财务官、财务执行副总裁和总法律顾问。她还在2019年10月至2021年2月期间担任Clinigence Holdings，Inc.的董事。在Clinigence Holdings，Inc.，卢克曼负责维护公司的会计记录和报表，准备提交给SEC的文件，并监督合规要求。她是Clinigence Holdings，Inc.团队的重要成员，负责获得其在纳斯达克股票市场有限责任公司（“纳斯达克”）的上市，并完成与该公司的反向合并。在该公司，Luqman女士继续负责准备提交给SEC的文件，并监督合规要求。Luqman女士自2021年3月起担任Cardio的首席财务官。此外，卢克曼还与人共同创立了bigVault Storage Technologies，这是一家基于云的文件托管公司，于2006年2月被Digi-Data Corporation收购。从2006年3月至2009年2月，Luqman女士受聘担任Digi-Data公司保险库服务部首席运营官，随后在Digi-Data公司任职期间，她成为整个公司的总法律顾问。在这个职位上，她负责收购、合并、专利、客户、供应商和员工合同，并与Digi-Data的外部咨询公司密切合作。2009年3月，Luqman女士重新加入iGambit公司（“IGMB”），担任首席财务官和总法律顾问。从2010年IGMB首次向SEC提交表格10，到2019年10月IGMB与Clinigence Holdings，Inc.进行反向并购，卢克曼一直监督并负责IGMB向SEC提交的文件、FINRA文件和上市公司合规要求。Luqman女士在霍夫斯特拉大学获得文学学士、法学博士和金融专业工商管理硕士学位。卢克曼女士是纽约和新泽西律师协会的会员。
- Pamela Montgomery,has served as the Chief Legal Officer (SEC) of Nutex Health Inc. Company since April 1, 2022. She served as the Chief Financial Officer, Executive Vice President Finance and General Counsel of Clinigence Holdings, Inc. from October 2019 until the Merger. She also served as a director of Clinigence Holdings, Inc. from October 2019 to February 2021. At Clinigence Holdings, Inc., Ms. Luqman was responsible for maintaining the corporation's accounting records and statements, preparing its SEC filings and overseeing compliance requirements. She was an integral member of the Clinigence Holdings, Inc. team responsible for obtaining its NASDAQ Stock Market LLC ("NASDAQ") listing and completing the reverse merger with the Company. At the Company, Ms. Luqman continues to be responsible for preparing its SEC filings and overseeing compliance requirements. Ms. Luqman has served as Chief Financial Officer of Cardio since March 2021. In addition, Ms. Luqman co-founded bigVault Storage Technologies, a cloud- based file hosting company acquired by Digi-Data Corporation in February 2006. From March 2006 through February 2009, Ms. Luqman was employed as Chief Operating Officer of the Vault Services Division of Digi-Data Corporation, and subsequently during her tenure with Digi-Data Corporation she became General Counsel for the entire corporation. In that capacity she was responsible for acquisitions, mergers, patents, customer, supplier, and employee contracts, and worked very closely with Digi- Data's outside counsel firms. In March 2009, Ms. Luqman rejoined iGambit Inc. ("IGMB") as Chief Financial Officer and General Counsel. Ms. Luqman has overseen and been responsible for IGMB's SEC filings, FINRA filings and public company compliance requirements from its initial Form 10 filing with the SEC in 2010 through its reverse merger with Clinigence Holdings, Inc. in October 2019. Ms. Luqman received a Bachelor of Arts, a Juris Doctor, and a Master of Business Administration with a specialization in Finance from Hofstra University. Ms. Luqman is a member of the bar in New York and New Jersey.
- Michael L. Chang
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Wesley Bamburg
Wesley Bamburg，自2024年7月起担任HCA Houston Healthcare North Cypress的首席运营官。在此之前，2019年至2024年，Bamburg先生担任德克萨斯州休斯顿HCA休斯顿医疗保健医疗中心的首席运营官。Bamburg先生的职业生涯始于2013年的HCA健康护理，担任墨西哥湾沿岸分部Payor Contracting & Alignment副总裁（VP）。在加入HCA健康护理之前，Bamburg先生有一个独特的机会在11个州的区域工作，专注于管理式医疗、网络运营和医生联盟，从付款人和提供者的角度都有综合经验。班堡以运动奖学金的方式就读于西南俄克拉荷马州立大学，在那里他获得了医疗管理学士学位和俄克拉荷马城市大学的工商管理硕士学位。
Wesley Bamburg,served as Chief Operating Officer for HCA Houston Healthcare North Cypress since July 2024. Before that, from 2019 to 2024, Mr. Bamburg was Chief Operating Officer at HCA Houston Healthcare Medical Center, Houston, TX. Mr. Bamburg began his career with HCA Healthcare in 2013 as the Gulf Coast Division's Vice President (VP) of Payor Contracting & Alignment. Prior to joining HCA Healthcare, Mr. Bamburg had the unique opportunity to work regionally in 11 states, concentrating in managed care, network operations and physician alignment with combined experience from both the payor and provider perspective.Mr. Bamburg attended Southwestern Oklahoma State University on an athletic scholarship where he earned his Bachelor's Degree in Healthcare Administration and his Master of Business Administration from Oklahoma City University.- Wesley Bamburg，自2024年7月起担任HCA Houston Healthcare North Cypress的首席运营官。在此之前，2019年至2024年，Bamburg先生担任德克萨斯州休斯顿HCA休斯顿医疗保健医疗中心的首席运营官。Bamburg先生的职业生涯始于2013年的HCA健康护理，担任墨西哥湾沿岸分部Payor Contracting & Alignment副总裁（VP）。在加入HCA健康护理之前，Bamburg先生有一个独特的机会在11个州的区域工作，专注于管理式医疗、网络运营和医生联盟，从付款人和提供者的角度都有综合经验。班堡以运动奖学金的方式就读于西南俄克拉荷马州立大学，在那里他获得了医疗管理学士学位和俄克拉荷马城市大学的工商管理硕士学位。
- Wesley Bamburg,served as Chief Operating Officer for HCA Houston Healthcare North Cypress since July 2024. Before that, from 2019 to 2024, Mr. Bamburg was Chief Operating Officer at HCA Houston Healthcare Medical Center, Houston, TX. Mr. Bamburg began his career with HCA Healthcare in 2013 as the Gulf Coast Division's Vice President (VP) of Payor Contracting & Alignment. Prior to joining HCA Healthcare, Mr. Bamburg had the unique opportunity to work regionally in 11 states, concentrating in managed care, network operations and physician alignment with combined experience from both the payor and provider perspective.Mr. Bamburg attended Southwestern Oklahoma State University on an athletic scholarship where he earned his Bachelor's Degree in Healthcare Administration and his Master of Business Administration from Oklahoma City University.